Rosetta Exosome
Latest round
- Series A
Last raised
- Apr 2021
Total raised
- $7.2M
Investors
- 4
About Rosetta Exosome
Based in Gyeonggi-do, South Korea, and founded in 2016 by co-founders Yong Shong and Kwang Pyo Kim, Rosetta Exosome Inc. operates as a developer of proprietary and integrated next-generation platform technologies for the development of innovative exosome-based diagnostics and therapeutics against intractable diseases. In April 2021, Rosetta Exosome Inc. The company offers the ExoLutE Exosome Isolation Kit, an ultracentrifugation-reproducible next-generation technology for extracellular vesicle isolation from mammalian cell-conditioned medium and biological fluids. The technology enables the mass production of exosomes from microorganisms other than human-derived stem cells, increasing the possibility of developing therapeutics using exosomes.
Who invested in Rosetta Exosome
4 investors across 1 round
See all investors in Rosetta Exosome
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 27, 2021
Amount
$7.2M
Investors
Questions about Rosetta Exosome
Who invested in Rosetta Exosome?
Rosetta Exosome has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rosetta Exosome raised?
Rosetta Exosome has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Rosetta Exosome last raise money?
Rosetta Exosome's most recent round on record is a Series A, in Apr 2021.
What does Rosetta Exosome do?
Based in Gyeonggi-do, South Korea, and founded in 2016 by co-founders Yong Shong and Kwang Pyo Kim, Rosetta Exosome Inc.
Where is Rosetta Exosome headquartered?
Rosetta Exosome is headquartered in Gyeonggi-do, South Korea.
Which VCs invest in companies like Rosetta Exosome?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Rosetta Exosome's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Rosetta Exosome? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.